Drug profile · INN
propofol
DIPRIVAN
propofol (DIPRIVAN) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — propofol
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 3
- Programs
- 16
- Data quality
- 0.89
Quick answer
propofol (DIPRIVAN) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
GABA-A receptor; anion channel positive allosteric modulator
Primary target: GABA-A receptor; anion channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is propofol?
propofol (DIPRIVAN) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for propofol?
DIPRIVAN is a marketed brand name for propofol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of propofol?
propofol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.